Email Alert | RSS

Chinese Journal of Antituberculosis ›› 2026, Vol. 48 ›› Issue (9): 1375-1385.doi: 10.19982/j.issn.1000-6621.20260166

• Original Articles • Previous Articles     Next Articles

Quality evaluation of tuberculosis prevention and control work in Guangxi based on Entropy Weight-TOPSIS and RSR method

Huang Quanjiang1, Huang Minying2, Cui Zhezhe2()   

  1. 1 School of Public Health, Youjiang Medical University for Nationalities, Baise 533000, China
    2 Guangxi Zhuang Autonomous Region Center for Disease Control and Prevention, Tuberculosis Prevention and Control Institute (Guangxi Zhuang Autonomous Region Academy of Preventive Medicine)/Key Discipline Platform for Tuberculosis Prevention and Control of Guangxi, Nanning 530028, China
  • Received:2026-03-27 Online:2026-09-10 Published:2026-09-08
  • Contact: Cui Zhezhe E-mail:czz6997@163.com
  • Supported by:
    Guangxi Disease Prevention and Control Science and Technology Project(GXJKKJ24Z003);Guangxi Natural Science Foundation Key Project(2026GXNSFD202160011)

Abstract:

Objective: To explore the key indicators influencing the comprehensive evaluation through the comprehensive quality assessment of tuberculosis prevention and control work in cities of Guangxi Zhuang Autonomous Region from 2021 to 2024, so as to provide a reference for cities to improve the quality of tuberculosis prevention and control. Methods: A comprehensive evaluation of tuberculosis prevention and control performance across various cities was carried out by integrating the entropy-weighted Technique for Order Preference by Similarity to Ideal Solution (TOPSIS) with the rank-sum ratio (RSR) method. Results: There were significant regional differences in the comprehensive evaluation of tuberculosis control efforts across 14 cities in Guangxi Zhuang Autonomous Region. Laibin and Hezhou consistently ranked in the higher tier (Probit >6). Baise, Yulin, Wuzhou, Chongzuo, Beihai, and Qinzhou remained in the middle tier over time (4≤Probit≤6). Nanning, Fangchenggang, Guigang, Hechi, Liuzhou, and Guilin showed certain fluctuations in their evaluations: Nanning was in the lower tier (Probit <4) from 2022 to 2023 but jumped to the upper tier (Probit >6) in 2024; Fangchenggang was in the middle tier (4≤Probit≤6) from 2021 to 2023 but dropped to the lower tier (Probit <4) in 2024; Liuzhou was in the lower tier (Probit <4) from 2021 to 2022 but rose to the middle tier (4≤Probit≤6) from 2023 to 2024; Guigang was in the middle tier (4≤Probit≤6) from 2021 to 2022 but declined to the lower tier (Probit <4) for two consecutive years from 2023 to 2024. Cluster analysis revealed marked regional differentiation in pulmonary tuberculosis prevention and control quality across Guangxi. The northern region exhibited stable growth; the central region showed polarization, with Nanning characterized as high-start and high-growth, while Guigang and Laibin were classified as slow decline and fluctuating adjustment types, respectively; the eastern region and southern coastal areas (except Fangchenggang) were fluctuating adjustment types, whereas Fangchenggang was a rapid decline type; the western and border regions displayed the strongest spatial heterogeneity, with Chongzuo showing stable growth, Hechi exhibiting slow decline, and Baise being fluctuating adjustment. Lag-one-year correlation analysis did not reveal a significant relationship between the comprehensive score of tuberculosis control performance and changes in reported incidence rate (r=-0.019, P=0.950) or mortality rate (ρ=-0.167, P=0.568). Conclusion: The quality of tuberculosis prevention and control efforts across Guangxi demonstrates considerable instability. Certain areas in the western and central regions—potentially influenced by a high epidemic burden and socioeconomic constraints—have persistently performed at suboptimal levels. The current performance evaluation indicators do not directly capture the impact on epidemic trends.

Key words: Entropy weight-TOPSIS, Ranksum ratio method, Tuberculosis, Quality of health care, Outcome assessment (health care)

CLC Number: